SCHEMBL16666104

SCHEMBL16666104

S=C(Nc1ccncc1I)NC1CCCC1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.58
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ PKM P14618 1/20 0.49
▸ LMNA P02545 2/20 0.48
▸ MAPT P10636 2/20 0.48
▸ GAA P10253 1/20 0.48
▸ ALOX12 P18054 1/20 0.48
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ HTT P42858 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9425866 0.82 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2LMNAMAPTGAA
SCHEMBL9426354 0.82 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2PKMLMNAMAPT
SCHEMBL9426037 0.81 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2LMNAMAPTGAA
SCHEMBL9425868 0.78 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2LMNAMAPTGAA
SCHEMBL9425921 0.78 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2LMNAGAAALOX12
SCHEMBL9426269 0.77 ALDH1A1 (0.63) ALDH1A1SMN1; SMN2PKMLMNAMAPT
SCHEMBL9426788 0.76 NPC1 (0.60) ALDH1A1SMN1; SMN2LMNAMAPTMEN1
Hydrochloric Acid SCHEMBL9426281 0.76 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2PKMLMNAMAPT
SCHEMBL9426543 0.75 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2LMNAMAPTGAA
SCHEMBL9426020 0.73 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2PKMLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015055994-A1 CYCLOPENTYLBENZAMIDE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PSYCHOTIC AND COGNITIVE DISORDERS TAKEDA CAMBRIDGE LIMITED (GB) 2015-04-23 — — WO disclosed
Send feedback